14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today AVEO ranks #14675 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

AVEO Pharmaceuticals Stock Forecast NASDAQ:AVEO

$5.34 (-6.64%)

Volume: 338k

Closed: Dec 03, 2021

Hollow Logo Score: -3.981

AVEO Pharmaceuticals Stock Forecast

$5.34 (-6.64%)

Volume: 338k

Closed: Dec 03, 2021

Score Hollow Logo -3.981
Which way will AVEO go? Request
Key Stats
P/E Ratio -3.19
Beta 1.14
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 75 ] RSI14 is 9 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.

Is AVEO Pharmaceuticals stock still a buy after falling -6.64% on Friday ?
(Updated on Dec 03, 2021)

Sell candidate since 2021-12-03

The AVEO Pharmaceuticals stock price fell by -6.64% on the last day (Friday, 3rd Dec 2021) from $5.72 to $5.34. and has now fallen 7 days in a row. During the day the stock fluctuated 7.94% from a day low at $5.29 to a day high of $5.71. The price has fallen in 8 of the last 10 days and is down by -20.18% for this period. Volume has increased on the last day by 20 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 338 thousand shares were bought and sold for approximately $1.80 million.

Given the current short-term trend, the stock is expected to rise 2.01% during the next 3 months and, with a 90% probability hold a price between $5.45 and $7.58 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The AVEO Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.09 and $6.72. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -27.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.42 between high and low, or 7.94%. For the last week, the stock has had a daily average volatility of 7.08%.

AVEO Pharmaceuticals is oversold on RSI14 (9). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is AVEO Pharmaceuticals stock A Buy?

The AVEO Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe AVEO Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.981

Predicted Opening Price for AVEO Pharmaceuticals of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$5.45 $5.34 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 15, 2021 "SVB Leerink" gave "$18.00" rating for AVEO. The price target was changed from $7.28 to 1.6%.

Volatility and Risk
Daily Average Volatility: 7.08 %
Overall Risk: Very High High Medium Low Very Low
7.08 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $6.45
Price: $5.34
No Support Found

AVEO Insider Trading Show all Trades


Last 100 transactions
Buy: 100 687 541 | Sell: 0 (Shares)
Date Action Amount Person Type
Dec 01, 2021 Buy 170 000 Ledell Jebediah Stock Option (right to buy)
Sep 01, 2021 Buy 15 000 Bailey Michael P Common Stock
Aug 10, 2021 Buy 2 608 Ferraresso Michael Common Stock
Jun 09, 2021 Buy 12 500 Evnin Anthony B Stock Option (right to buy)
Jun 09, 2021 Buy 12 500 Bate Kenneth Stock Option (right to buy)
Show all Insider Trades

Last 100 transactions
Buy: 100 687 541 | Sell: 0 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 5.87 9.86 %
5.71 6.86 %
5.61 5.00 %
Current price: 5.34
Support 5.29 -1.01 %
5.19 -2.86 %
5.03 -5.87 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 6.59 23.41 %
6.56 22.85 %
6.45 20.79 %
Current price 5.34
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About AVEO Pharmaceuticals

AVEO Pharmaceuticals AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. The company’s pipeline of product candidates include Tivozanib, an tyrosine kinase inhibitor for various vascular endothelial growth factors for renal cell carcinoma and other cancers; Ficlatuzumab, an anti-hepatocyte growth factor inhibitory antibody, which has completed Phase II trial; and AV-203, an anti-ErbB3 mo... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE